Fig. 2
From: Spinal muscular atrophy with hypoplasia of the corpus callosum: a case report
Changes in total scores of the Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND) and the Hammersmith Infant Neurological Examination -2 (HINE-2) from baseline, and changes in compound muscle action potential (CMAP) amplitude. A, Changes in the total scores of CHOP-INTEND (the blue line) and HINE-2(the red line) from baseline at 18 months old to 40 months old. B, Changes in CMAP amplitude from baseline at 18 months old to 40 months old. The dashed black line denotes he started to receive nusinersen